Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Functional anatomy and impact of cognitive training on chunking within working memory in early Alzheimer's disease
ISRCTN ISRCTN43007027
ClinicalTrials.gov identifier
Public title Functional anatomy and impact of cognitive training on chunking within working memory in early Alzheimer's disease
Scientific title Functional anatomy and impact of cognitive training on chunking within working memory in early Alzheimer's disease: a randomised controlled trial
Acronym N/A
Serial number at source Version 1 (13.7.10); G0901982
Study hypothesis 1. Training individuals with early Alzheimer's disease (AD) in the use of chunking strategies will improve their working memory (WM) capacity
2. Use of chunking strategies in early AD will correlate with significantly increased activity in the prefrontal cortex (PFC) and posterior parietal cortex (PPC)
3. Following training in chunking, improvement in WM capacity will generalise across different modalities of WM tasks and measures of general cognitive functioning
4. Improvements in WM following cognitive training will be associated with structural and functional re-organisation of brain activity
Lay summary
Ethics approval Cambridgeshire 1 Research Ethics Committee approved on the 21st October 2010 (ref: 10/H0304/68)
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Early Alzheimer's disease
Participants - inclusion criteria 1. Aged greater than 60 years, either sex
2. Diagnosis of probable Alzheimer's disease according to National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
3. Mini-Mental State Examination (MMSE) score greater than 23/30
4. All subjects will be required to provide informed consent to participate in the study
Participants - exclusion criteria 1. Co-existent neurological or psychiatric disease
2. Substance misuse
3. Significant auditory or visual impairment
Anticipated start date 20/12/2010
Anticipated end date 05/08/2014
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 30
Interventions Subjects will be randomly allocated to either a cognitive training group or control group. The cognitive training group will undergo 18 days of training over 6 weeks for approximately 45 minutes/day. Each training session will consist of 30 trials of structured span tasks. The length of span will be adjusted after each trial depending on whether it is correctly recalled. Each subject will therefore be continually tested at their span limit, which can adjust both within and across sessions. The control group will perform 30 trials of a 2 span unstructured task over the same time period. After 6 weeks of training, subjects will be reassessed using the baseline battery of tasks, and re-imaged with functional magnetic resonance imaging (fMRI) performing the same verbal chunking task protocol.
Primary outcome measure(s) 1. Scores on verbal working memory task
2. Cerebral blood flow in the prefrontal and parietal cortices as measured using fMRI

Measured at baseline and after 8 weeks (following the 6 week cognitive training intervention).
Secondary outcome measure(s) Scores on:
1. Spatial working memory task
2. Sustained attention, reasoning and episodic memory tasks
3. Artificial grammar task
4. Instrumental activities of daily living (ADL) task

Measured at baseline and after 8 weeks (following the 6 week cognitive training intervention).
Sources of funding Medical Research Council (MRC) (UK) (ref: G0901982/ ID 93849)
Trial website
Publications
Contact name Dr  Jonathan  Huntley
  Address Institute of Psychiatry
De Crespigny Park
  City/town London
  Zip/Postcode SE5 8AZ
  Country United Kingdom
Sponsor Institute of Psychiatry (UK)
  Address c/o Professor Robert Howard
Kings College London
De Crespigny Park
  City/town London
  Zip/Postcode SE5 8AF
  Country United Kingdom
  Sponsor website: http://www.iop.kcl.ac.uk/
Date applied 10/12/2010
Last edited 07/02/2011
Date ISRCTN assigned 07/02/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central